Thanks for posting it. It shows how a single targeting product...

Thanks for posting it. It shows how a single targeting product is going to be analgesic at very best. To address OA you need a multi modal approach. OA is not specific, limited and contained only to the inner cavity or aspect of a given joint.

It is all encompassing and eventually leads to whole of joint failure.

There isn't just one independant aspect you need to approach. You need to address primarily inflammation but all the other processes too...Even addressing inflammation cant be just blocking it totally.

From within cells (NFkB) to being a mild anti thrombotic, there are many pathways to cause a positive effect here.

Finally it is the body that needs to do the repair work...regression of BMELS...rescinding the osteophytes...heck even bringing down pain, you can't just block it out. It sounds obvious but they only realised that OA is all encompassing a decade or so ago.